The value of growth hormone supplements in ART for poor ovarian responders

被引：55
作者：
de Ziegler, Dominique [1 ]
Streuli, Isabelle [1 ,2 ]
Meldrum, David R. [3 ,4 ]
Chapron, Charles [1 ,2 ]
机构：
[1] Univ Paris 05, AP HP, CHU Cochin, Dept Obstet Gynecol & Reprod Med, Paris, France
[2] CNRS, Cochin Inst, UMR 8104, ISERM,U1016, Paris, France
[3] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA
[4] Reprod Partners Med Grp Redondo Beach Calif, Los Angeles, CA USA
来源：
FERTILITY AND STERILITY | 2011年 / 96卷 / 05期
关键词：
Growth hormone; assisted reproductive technologies; ART; poor response; controlled ovarian stimulation; COS; ovarian failure; aging; IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; STRUCTURE ASSAY PARAMETERS; FACTOR BINDING PROTEIN-1; LIVE BIRTH-RATES; DOUBLE-BLIND; PREGNANCY RATES; GONADOTROPIN STIMULATION; INVITRO FERTILIZATION; OVULATION INDUCTION;
D O I：
10.1016/j.fertnstert.2011.09.049
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Recently, three meta-analyses have concluded that cotreatment with GH improves assisted reproduction outcome in poor controlled ovarian stimulation responders. Although generally GH supplements did not increase controlled ovarian stimulation response or number of oocytes, the supplements improved pregnancy and live-birth rates-thus speaking for an effect on oocyte quality. (Fertil Steril (R) 2011;96:1069-76. (C) 2011 by American Society for Reproductive Medicine.)
引用
收藏
页码：1069 / 1076
页数：8
相关论文
共 95 条
  • [1] ABBASI R, 1987, FERTIL STERIL, V47, P1019
  • [2] INSULIN-LIKE GROWTH-FACTORS AS INTRAOVARIAN REGULATORS OF GRANULOSA-CELL GROWTH AND FUNCTION
    ADASHI, EY
    RESNICK, CE
    DERCOLE, AJ
    SVOBODA, ME
    VANWYK, JJ
    [J]. ENDOCRINE REVIEWS, 1985, 6 (03) : 400 - 420
  • [3] Growth hormone for in vitro fertilization
    Ahmad, Gaity
    Brown, Julie
    Duffy, James M. N.
    Nardo, Luciano G.
    Watson, Andrew
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [4] Ovarian response to repeated controlled stimulation in in-vitro fertilization cycles in patients with ovarian endometriosis
    Al-Azemi, M
    Bernal, AL
    Steele, J
    Gramsbergen, I
    Barlow, D
    Kennedy, S
    [J]. HUMAN REPRODUCTION, 2000, 15 (01) : 72 - 75
  • [5] Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist
    Bahceci, Mustafa
    Ulug, Ulun
    Turan, Ersadik
    Akman, Mehmet Ali
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2007, 130 (01): : 93 - 98
  • [6] Effect of endometriosis on in vitro fertilization
    Barnhart, K
    Dunsmoor-Su, R
    Coutifaris, C
    [J]. FERTILITY AND STERILITY, 2002, 77 (06) : 1148 - 1155
  • [7] BERGH C, 1994, FERTIL STERIL, V62, P113
  • [8] Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation
    Blockeel, Christophe
    Schutyser, Valerie
    De Vos, Anick
    Verpoest, Willem
    De Vos, Michel
    Staessen, Catherine
    Haentjens, Patrick
    Van der Elst, Josiane
    Devroey, Paul
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2008, 17 (06) : 848 - 854
  • [9] Ovarian Aging: Mechanisms and Clinical Consequences
    Broekmans, F. J.
    Soules, M. R.
    Fauser, B. C.
    [J]. ENDOCRINE REVIEWS, 2009, 30 (05) : 465 - 493
  • [10] AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis
    Broer, S. L.
    Dolleman, M.
    Opmeer, B. C.
    Fauser, B. C.
    Mol, B. W.
    Broekmans, F. J. M.
    [J]. HUMAN REPRODUCTION UPDATE, 2011, 17 (01) : 46 - 54
12345678910